BR112022008533A2 - Composição para aumento da biodisponibilidade sanguínea de aminoácidos, seu uso, produto alimentício, uso de uma mistura, e usos de cepas bacterianas probióticas - Google Patents

Composição para aumento da biodisponibilidade sanguínea de aminoácidos, seu uso, produto alimentício, uso de uma mistura, e usos de cepas bacterianas probióticas

Info

Publication number
BR112022008533A2
BR112022008533A2 BR112022008533A BR112022008533A BR112022008533A2 BR 112022008533 A2 BR112022008533 A2 BR 112022008533A2 BR 112022008533 A BR112022008533 A BR 112022008533A BR 112022008533 A BR112022008533 A BR 112022008533A BR 112022008533 A2 BR112022008533 A2 BR 112022008533A2
Authority
BR
Brazil
Prior art keywords
mixture
amino acids
food product
composition
bacterial strains
Prior art date
Application number
BR112022008533A
Other languages
English (en)
Inventor
Biffi Andrea
FIORE Walter
Original Assignee
Sofar Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sofar Spa filed Critical Sofar Spa
Publication of BR112022008533A2 publication Critical patent/BR112022008533A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/185—Vegetable proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Mycology (AREA)
  • Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

COMPOSIÇÃO PARA AUMENTO DA BIODISPONIBILIDADE SANGUÍNEA DE AMINOÁCIDOS, SEU USO, PRODUTO ALIMENTÍCIO, USO DE UMA MISTURA, E USOS DE CEPAS BACTERIANAS PROBIÓTICAS. A presente invenção se refere a composições para uso em aumento da biodisponibilidade sanguínea de aminoácidos derivados de proteínas, preferivelmente proteínas de origem de planta, sendo que as referidas composições compreendem uma mistura M compreendendo ou, alternativamente, consistindo em pelo menos uma cepa bacteriana, preferivelmente Lactobacillus paracasei DGR CNCM I-1572 e/ou Lactobacillus paracasei LPC-S01TM DSM 26760. Ainda, a presente invenção refere-se às referidas composições para uso compreendendo ainda pelo menos uma proteína, preferivelmente proteínas de origem de planta, ou um peptídeo ou um aminoácido. Por fim, a presente invenção refere-se a um produto alimentício compreendendo proteínas, preferivelmente de origem de planta, e a referida mistura M de pelo menos uma cepa bacteriana.
BR112022008533A 2019-11-05 2020-11-05 Composição para aumento da biodisponibilidade sanguínea de aminoácidos, seu uso, produto alimentício, uso de uma mistura, e usos de cepas bacterianas probióticas BR112022008533A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT102019000020422A IT201900020422A1 (it) 2019-11-05 2019-11-05 Composizioni comprendenti ceppi di batteri per uso per aumentare la biodisponibilità degli amminoacidi derivanti da proteine
PCT/IB2020/060412 WO2021090228A1 (en) 2019-11-05 2020-11-05 Compositions comprising bacterial strains for use in increasing the bioavailability of amino acids derived from proteins

Publications (1)

Publication Number Publication Date
BR112022008533A2 true BR112022008533A2 (pt) 2022-08-09

Family

ID=69903771

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112022008533A BR112022008533A2 (pt) 2019-11-05 2020-11-05 Composição para aumento da biodisponibilidade sanguínea de aminoácidos, seu uso, produto alimentício, uso de uma mistura, e usos de cepas bacterianas probióticas

Country Status (10)

Country Link
US (1) US20220409676A1 (pt)
EP (1) EP4054610A1 (pt)
JP (1) JP2023507064A (pt)
CN (1) CN115768450A (pt)
BR (1) BR112022008533A2 (pt)
CA (1) CA3160295A1 (pt)
CO (1) CO2022006972A2 (pt)
IT (1) IT201900020422A1 (pt)
MX (1) MX2022005412A (pt)
WO (1) WO2021090228A1 (pt)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20131467A1 (it) 2013-09-06 2015-03-07 Sofar Spa Uso di una composizione comprendente microrganismi per aumentare la produzione intestinale di acido butirrico, di acido folico o di niacina e/o per diminuire la produzione intestinale di acido succinico
MA39710A (fr) 2014-04-23 2015-10-29 Sofar Spa Composition topique destinée à être utilisée dans le traitement d'une maladie inflammatoire de l'intestin
MA45327A (fr) 2016-05-13 2019-03-20 Sofar Spa Utilisation de probiotiques pour améliorer l'absorption des protéines
MA45288A (fr) 2016-06-08 2019-04-17 Sofar Spa Nouvelle utilisation médicale de probiotiques
IT201600122724A1 (it) 2016-12-02 2018-06-02 Sofar Spa Exopolysaccharides and uses thereof
IT201600127498A1 (it) 2016-12-16 2018-06-16 Sofar Spa Probiotici per uso nella diverticolosi e malattia diverticolare
US11751597B2 (en) 2019-11-05 2023-09-12 Alfasigma S.P.A. Compositions comprising bacterial strains for use in increasing the bioavailability of amino acids derived from proteins, and related food product methods and systems
IT202100018740A1 (it) * 2021-07-15 2023-01-15 Sofar Spa Uso di ceppi di batteri Lactobacillus paracasei nel trattamento di neonati
CN118256398B (zh) * 2024-05-29 2024-09-20 善恩康生物科技（苏州）有限公司 高产谷氨酰胺的副干酪乳酪杆菌及其应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010103132A1 (es) * 2009-03-10 2010-09-16 Hero España, S.A. Aislamiento, identificación y caracterización de cepas con actividad probiótica a partir de heces de lactantes alimentados exclusivamente con leche materna
WO2015172191A1 (en) * 2014-05-12 2015-11-19 Medlab Ip Pty Ltd Probiotic compositions and uses thereof for treatment of obesity-related disorders
MA45327A (fr) * 2016-05-13 2019-03-20 Sofar Spa Utilisation de probiotiques pour améliorer l'absorption des protéines
WO2017195182A1 (en) * 2016-05-13 2017-11-16 Sofar S.P.A. Use of probiotics for improving protein absorption
IT201900016811A1 (it) * 2019-09-20 2021-03-20 Sofar Spa Ceppi batterici, loro composizioni e loro uso per il trattamento di disturbi gastrointestinali
IT201900016805A1 (it) * 2019-09-20 2021-03-20 Sofar Spa Ceppi batterici, loro composizioni e loro uso per il trattamento di disturbi gastrointestinali

Also Published As

Publication number Publication date
JP2023507064A (ja) 2023-02-21
CN115768450A (zh) 2023-03-07
MX2022005412A (es) 2022-08-25
WO2021090228A1 (en) 2021-05-14
EP4054610A1 (en) 2022-09-14
US20220409676A1 (en) 2022-12-29
CO2022006972A2 (es) 2022-08-19
CA3160295A1 (en) 2021-05-14
WO2021090228A4 (en) 2021-07-01
IT201900020422A1 (it) 2021-05-05

Similar Documents

Publication Publication Date Title
BR112022008533A2 (pt) Composição para aumento da biodisponibilidade sanguínea de aminoácidos, seu uso, produto alimentício, uso de uma mistura, e usos de cepas bacterianas probióticas
Fontoura et al. Production of feather hydrolysates with antioxidant, angiotensin-I converting enzyme-and dipeptidyl peptidase-IV-inhibitory activities
Song et al. Antioxidant and antibacterial activity and in vitro digestion stability of cottonseed protein hydrolysates
Sun et al. Isolation and characterization of an antibacterial peptide from protein hydrolysates of Spirulina platensis
BR112022004527A2 (pt) Composições com base em cepas bacterianas e seu uso como anti-inflamatórios
Mollea et al. Valorisation of cheese whey, a by-product from the dairy industry
Gaspar‐Pintiliescu et al. Angiotensin‐converting enzyme inhibition, antioxidant activity and cytotoxicity of bioactive peptides from fermented bovine colostrum
AU2008341708B2 (en) Microorganisms for improving the health of individuals with disorders related to gluten ingestion
BR112022004976A2 (pt) Composições com base em cepas bacterianas e extratos de baga e uso do mesmo como anti-inflamatórios
Elfahri et al. Potential of novel Lactobacillus helveticus strains and their cell wall bound proteases to release physiologically active peptides from milk proteins
Oh et al. Preventive effect of fermented Maillard reaction products from milk proteins in cardiovascular health
MX2019010638A (es) Modificadores de sabor para productos analogos de carne.
MX2012004738A (es) Producto de la proteina de suero de leche y un metodo para su preparacion.
Cheng et al. Antibacterial effect and hydrophobicity of yak κ-casein hydrolysate and its fractions
Ren et al. Purification and characterization of antioxidant peptide from sunflower protein hydrolysate
Taha et al. Antioxidant and antimicrobial activities of enzymatic hydrolysis products from sunflower protein isolate
CN115697069A (zh) 低变应原性重组乳蛋白和包含其的组合物
Hayes et al. Bioactive compounds from fermented food products
UA93556C2 (ru) Инокулят, содержащий b смеси или комбинации цистеин и bifidobacterium animalis lactis, применение инокулята и ферментированные молочные продукты, полученные c помощью инокулята
Lafarga Potential applications of plant‐derived proteins in the food industry
WO2011014925A1 (en) Process for obtaining peptide fractions
Hrnjez et al. Nutritive aspects of fermented dairy products obtained by kombucha application
AR120748A1 (es) Preparación que comprende cepas probióticas y proceso para identificar consorcios de cepas probióticas adecuadas para la degradación del gluten
Pritchard Isolation and characterisation of bioactive peptides derived from milk and cheese
Lai et al. Processing stability of antioxidant protein hydrolysates extracted from degreased walnut meal